U.S., Dec. 11 -- ClinicalTrials.gov registry received information related to the study (NCT07274358) titled 'HopeMove App in Pediatric Cancer Patients' on Nov. 27.
Brief Summary: This pilot feasibility study aims to assess the acceptability, usability, safety, and initial effects of the HopeMove mobile health app on fatigue in adolescents aged 13 to 18 years undergoing hematology-oncology treatment. HopeMove is a wearable-compatible app that offers guided home exercise sessions and daily symptom tracking to support physical activity and monitor well-being during treatment. The study includes an expert usability evaluation with 10 clinicians, a one-week usability testing phase with 15 adolescents, and an eight-week intervention period in wh...